Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Outlook Therapeutics, Inc. (OTLK)

0.4364 -0.0027 (-0.61%)
At close: November 6 at 4:00:01 PM EST
0.4410 +0.0046 (+1.05%)
Pre-Market: 4:01:24 AM EST

Financials

Updated 2d ago
Powered by Yahoo Scout

Outlook Therapeutics Incshows a mixed quarter-to-quarter picture across FY 2026 Q1 to FY 2026 Q3. Revenue growth, EPS growth, and valuation ratios stayed flat at 0.00% or 0.00x, suggesting no visible top-line momentum or earnings-based rerating in the period. EBITDA growthwas volatile, swinging from +100.00% in FY 2026 Q1to -100.00% in FY 2026 Q2, then back to +100.00% in FY 2026 Q3. Free cash flow yieldimproved from -0.21 in FY 2026 Q1to 0.15 in FY 2026 Q2, then eased to 0.06 in FY 2026 Q3, pointing to modest but uneven cash generation.

Valuation Measures

Currency in USD Download
Current 6/30/2026 3/31/2026 12/31/2025 9/30/2025 6/30/2025
Market Cap
106.24M 254.64M 21.53M 101.30M 47.08M 68.57M
Enterprise Value
113.43M 274.08M 49.75M 123.41M 72.88M 94.33M
Trailing P/E
-- -- -- -- -- --
Forward P/E
6.37 -- -- -- -- --
PEG Ratio (current)
-- -- -- -- -- --
Price/Sales
-- -- -- -- -- --
Price/Book
-- -- -- -- -- --
Enterprise Value/Revenue
436.88 644.99 167.22 87.31 48.42 --
Enterprise Value/EBITDA
-- -- -- -- -- 4.59
6/30/2025 - 6/14/2016

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends --
Most Recent Quarter (mrq) --

Profitability

Profit Margin --
Operating Margin (ttm) --

Management Effectiveness

Return on Assets (ttm) --
Return on Equity (ttm) --

Income Statement

Revenue (ttm) --
Revenue Per Share (ttm) --
Quarterly Revenue Growth (yoy) --
Gross Profit (ttm) --
EBITDA --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Quarterly Earnings Growth (yoy) --

Balance Sheet

Total Cash (mrq) --
Total Cash Per Share (mrq) --
Total Debt (mrq) --
Total Debt/Equity (mrq) --
Current Ratio (mrq) --
Book Value Per Share (mrq) --

Cash Flow Statement

Operating Cash Flow (ttm) --
Levered Free Cash Flow (ttm) --

Trading Information

Stock Price History

Beta (5Y Monthly) --
52 Week Change 3 --
S&P 500 52-Week Change 3 --
52 Week High 3 --
52 Week Low 3 --
50-Day Moving Average 3 --
200-Day Moving Average 3 --

Share Statistics

Avg Vol (3 month) 3 --
Avg Vol (10 day) 3 --
Shares Outstanding 5 --
Implied Shares Outstanding 6 --
Float 8 --
% Held by Insiders 1 --
% Held by Institutions 1 --
Shares Short 4 --
Short Ratio 4 --
Short % of Float 4 --
Short % of Shares Outstanding 4 --
Shares Short (prior month ) 4 --

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 --
Trailing Annual Dividend Yield 3 --
5 Year Average Dividend Yield 4 --
Payout Ratio 4 --
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq  =  Most Recent Quarter
  • ttm  =  Trailing Twelve Months
  • yoy  =  Year Over Year
  • lfy  =  Last Fiscal Year
  • fye  =  Fiscal Year Ending

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: